Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Sanjiezhentong Capsule and GnRHa after conservative surgery for moderate-to-severe endometriosis
ChiCTR-IPR-17013692Phase 4Recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Dec 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of triptorelin and San Jie Zhen Tong in endometriosis (3 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoints: VAS score, Quality of life and 2 more. Started Dec 2017; status: recruiting.
02
Drugs
triptorelinSan Jie Zhen Tong
03
Conditions
endometriosis
Beyond the preview
Go deeper on ChiCTR-IPR-17013692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013692.